Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
Joaquim SegalésMariona PuigJordi RodonCarlos Avila-NietoJorge CarrilloGuillermo CanteroMaria Teresa TerrónSílvia CruzMariona PareraMarc Noguera-JulianNuria Izquierdo-UserosVíctor GuallarEnric VidalAlfonso ValenciaIgnacio BlancoJulian BlancoBonaventura ClotetJúlia Vergara-AlertPublished in: Proceedings of the National Academy of Sciences of the United States of America (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of COVID-19, is considered a zoonotic pathogen mainly transmitted human to human. Few reports indicate that pets may be exposed to the virus. The present report describes a cat suffering from severe respiratory distress and thrombocytopenia living with a family with several members affected by COVID-19. Clinical signs of the cat prompted humanitarian euthanasia and a detailed postmortem investigation to assess whether a COVID-19-like disease was causing the condition. Necropsy results showed the animal suffered from feline hypertrophic cardiomyopathy and severe pulmonary edema and thrombosis. SARS-CoV-2 RNA was only detected in nasal swab, nasal turbinates, and mesenteric lymph node, but no evidence of histopathological lesions compatible with a viral infection were detected. The cat seroconverted against SARS-CoV-2, further evidencing a productive infection in this animal. We conclude that the animal had a subclinical SARS-CoV-2 infection concomitant to an unrelated cardiomyopathy that led to euthanasia.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- hypertrophic cardiomyopathy
- lymph node
- endothelial cells
- left ventricular
- squamous cell carcinoma
- emergency department
- case report
- radiation therapy
- pulmonary embolism
- early stage
- atrial fibrillation
- cord blood
- sensitive detection
- loop mediated isothermal amplification
- real time pcr
- sentinel lymph node